Univec Conglomerate Inc
Change company Symbol lookup
Select an option...
UNVC Univec Conglomerate Inc
MRNA Moderna Inc
COTY Coty Inc
BAC Bank of America Corp
NIO NIO Inc
IO ION Geophysical Corp
PRU Prudential Financial Inc
HAWEM Hawaiian Electric Company Inc
CCFN CCFNB Bancorp Inc
WYNN Wynn Resorts Ltd
Go

Company profile

Univec Conglomerate Inc, formerly Univec, Inc. (Univec), is an integrated licensing, manufacturing, and marketing company operating two divisions dedicated to providing safer health products to patients and caregivers worldwide. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide. The physician and pharmaceutical services division assists pharmaceutical companies in marketing, fulfillment and tracking drug samples via an online system connecting pharmacies and managed payment providers. The Company also manufactures and markets sliding sheath syringes designed to protect patients and healthcare workers from needle stick injuries, in compliance with the federal needlestick safety and prevention act of the United States government.

Closing Price
$0.08
Day's Change
-0.0094 (-10.46%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0912
Day's Low
0.0795
Volume
(Light)
Volume:
2,248,357

10-day average volume:
3,037,357
2,248,357

Company Profile

Univec Conglomerate Inc, formerly Univec, Inc. (Univec), is an integrated licensing, manufacturing, and marketing company operating two divisions dedicated to providing safer health products to patients and caregivers worldwide. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide. The physician and pharmaceutical services division assists pharmaceutical companies in marketing, fulfillment and tracking drug samples via an online system connecting pharmacies and managed payment providers. The Company also manufactures and markets sliding sheath syringes designed to protect patients and healthcare workers from needle stick injuries, in compliance with the federal needlestick safety and prevention act of the United States government.

Valuation Ratios

No valuation ratios available.

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

No short interest available.

Share Information

UNVC is in a share class of common stock
Float
120.3M
Shares Outstanding
286.8M
Institutions Holding Shares
--
--

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • S. Robert GrassChmn.
  • David L DaltonPres.
  • Michael LesiskoCFO
  • Raphael LangfordCOO
  • William WooldridgeDir.

Address

  • 822 Guilford Ave Ste 208
  • Baltimore, MD 21202-3707
  • Phone: (443) 253-0194
  • Fax: (302) 636-5454
  • http://univec.com/

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.